Faa G, Nurchi V, Demelia L, Ambu R, Parodo G, Congiu T, Sciot R, Van Eyken P, Silvagni R, Crisponi G
Dipartimento di Citomorfologia-Sezione Anatomia Patologica, University of Cagliari, Italy.
J Hepatol. 1995 Mar;22(3):303-8. doi: 10.1016/0168-8278(95)80283-5.
BACKGROUND/AIMS: Determination of hepatic copper concentration is important in the diagnosis of Wilson's disease. We studied copper distribution in the cirrhotic liver of a patient who died of Wilson's disease.
A liver slice extending from the left to the right lobe was divided into 38 samples. Each sample was analyzed for copper content by Induced Coupled Plasma Atomic Emission Spectroscopy.
The mean copper concentration in the liver was 1370 micrograms/g dt. A striking variability, up to 2-3-fold, in copper levels was observed between the samples: the copper concentration ranged from 880 to 2100 micrograms/g dt, with significant differences even between adjacent samples. Lobar differences were also observed, with a tendency of the right lobe to accumulate more copper than the left lobe. Histochemical analyses confirmed the uneven distribution of copper even at the acinar level. Copper was mainly stored in periportal hepatocytes (zone 1) and at the periphery of the regenerating nodules. Moreover, we observed some nodules with the majority of hepatocytes full of copper granules, adjacent to areas of parenchyma negative for copper stains.
Our data show that: 1) copper is unevenly distributed in Wilson's disease in the cirrhotic stage; 2) a lobar pattern of copper distribution is evident in this case, characterized by a higher copper concentration in the right lobe; 3) the observed lobar pattern is different from that described in the newborn liver, characterized by a higher copper content in the left compartment of the liver; 4) copper content determined in a small liver sample cannot be considered as absolutely representative of the mean hepatic copper concentration. From a practical point of view, our data show that sampling variability deserves more consideration in the diagnosis and in the monitoring of Wilson's disease. The use of hepatic copper concentration in monitoring the efficacy of the copper-chelating therapy may be unreliable, particularly in the cirrhotic stage, because of the patchy distribution of copper, as demonstrated in this study.
背景/目的:测定肝铜浓度对威尔逊病的诊断至关重要。我们研究了一名死于威尔逊病患者的肝硬化肝脏中的铜分布情况。
将一片从左叶延伸至右叶的肝脏切片分成38个样本。通过电感耦合等离子体原子发射光谱法分析每个样本的铜含量。
肝脏中铜的平均浓度为1370微克/克干重。样本间铜含量存在显著差异,高达2至3倍:铜浓度范围为880至2100微克/克干重,甚至相邻样本之间也存在显著差异。还观察到叶间差异,右叶比左叶有更多铜蓄积的趋势。组织化学分析证实即使在腺泡水平铜的分布也不均匀。铜主要储存在汇管区周围的肝细胞(1区)和再生结节的周边。此外,我们观察到一些结节,其中大多数肝细胞充满铜颗粒,与铜染色阴性的实质区域相邻。
我们的数据表明:1)在肝硬化阶段的威尔逊病中铜分布不均匀;2)在该病例中铜分布呈现叶间模式,其特征为右叶铜浓度较高;3)观察到的叶间模式与新生儿肝脏中描述的不同,后者肝脏左叶铜含量较高;4)在小肝脏样本中测定的铜含量不能被视为绝对代表肝脏铜的平均浓度。从实际角度来看,我们的数据表明在威尔逊病的诊断和监测中,样本变异性值得更多关注。如本研究所示,由于铜分布不均,在监测铜螯合疗法疗效时使用肝铜浓度可能不可靠,尤其是在肝硬化阶段。